Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Takeda

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 30, 2017
Dosimetric evaluation of MLC-based dynamic tumor tracking radiotherapy using digital phantom: Desired setup margin for tracking radiotherapyNoriyuki Kadoya, Kei Ichiji, Tomoya Uchida, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2007
A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancerMasashi Koto, Yoshihiro Takai, Yoshihiro Ogawa, et al.
Journal of Radiation Research|January 10, 2026
Evaluating the capability of large language models in radiotherapy through professional certification examinations in JapanNoriyuki Kadoya, Yoshiyuki Takahashi, Seiya Koga, et al.
BMC Cancer|November 23, 2012
Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II studyKeiichi Jingu, Haruo Matsushita, Ken Takeda, et al.
The Tohoku Journal of Experimental Medicine|January 8, 2011
Predicting the severity of acute urinary toxicity after brachytherapy with iodine-125 for localized prostate cancerKen Takeda, Keichi Jingu, Masashi Koto, et al.
Annals of Nuclear Medicine|June 5, 2015
Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapyTakaya Yamamoto, Noriyuki Kadoya, Yuko Shirata, et al.
Medical Physics|February 26, 2020
Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomicsNoriyuki Kadoya, Shohei Tanaka, Tomohiro Kajikawa, et al.
Journal of Radiation Research|April 18, 2021
Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single instituteTakaya Yamamoto, Yoshihide Kawasaki, Rei Umezawa, et al.
Cancer Science|September 23, 2024
Identification of ENO-1 positive extracellular vesicles as a circulating biomarker for monitoring of Ewing sarcomaKoji Uotani, Tomohiro Fujiwara, Koji Ueda, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 28, 2017
Impact of diesel exhaust exposure on the liver of mice fed on omega-3 polyunsaturated fatty acids-deficient dietMasakazu Umezawa, Masayuki Nakamura, Ashraf A El-Ghoneimy, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 30, 2017
Dosimetric evaluation of MLC-based dynamic tumor tracking radiotherapy using digital phantom: Desired setup margin for tracking radiotherapyNoriyuki Kadoya, Kei Ichiji, Tomoya Uchida, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2007
A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancerMasashi Koto, Yoshihiro Takai, Yoshihiro Ogawa, et al.
Journal of Radiation Research|January 10, 2026
Evaluating the capability of large language models in radiotherapy through professional certification examinations in JapanNoriyuki Kadoya, Yoshiyuki Takahashi, Seiya Koga, et al.
BMC Cancer|November 23, 2012
Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II studyKeiichi Jingu, Haruo Matsushita, Ken Takeda, et al.
The Tohoku Journal of Experimental Medicine|January 8, 2011
Predicting the severity of acute urinary toxicity after brachytherapy with iodine-125 for localized prostate cancerKen Takeda, Keichi Jingu, Masashi Koto, et al.
Annals of Nuclear Medicine|June 5, 2015
Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapyTakaya Yamamoto, Noriyuki Kadoya, Yuko Shirata, et al.
Medical Physics|February 26, 2020
Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomicsNoriyuki Kadoya, Shohei Tanaka, Tomohiro Kajikawa, et al.
Journal of Radiation Research|April 18, 2021
Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single instituteTakaya Yamamoto, Yoshihide Kawasaki, Rei Umezawa, et al.
Cancer Science|September 23, 2024
Identification of ENO-1 positive extracellular vesicles as a circulating biomarker for monitoring of Ewing sarcomaKoji Uotani, Tomohiro Fujiwara, Koji Ueda, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 28, 2017
Impact of diesel exhaust exposure on the liver of mice fed on omega-3 polyunsaturated fatty acids-deficient dietMasakazu Umezawa, Masayuki Nakamura, Ashraf A El-Ghoneimy, et al.
Pageof 25